News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,173 Results
Type
Article (40523)
Company Profile (282)
Press Release (652368)
Section
Business (206363)
Career Advice (2107)
Deals (35793)
Drug Delivery (91)
Drug Development (81361)
Employer Resources (171)
FDA (16165)
Job Trends (14904)
News (348297)
Policy (32859)
Tag
Academia (2567)
Alliances (49441)
Alzheimer's disease (1241)
Approvals (16094)
Artificial intelligence (131)
Bankruptcy (357)
Best Places to Work (11594)
Biotechnology (201)
Breast cancer (121)
Cancer (1091)
Cardiovascular disease (97)
Career advice (1761)
Cell therapy (237)
Clinical research (64636)
Collaboration (391)
Compensation (200)
COVID-19 (2567)
C-suite (98)
Data (1126)
Diabetes (153)
Diagnostics (6176)
Earnings (85899)
Employer resources (149)
Events (110504)
Executive appointments (318)
FDA (16706)
Funding (357)
Gene therapy (181)
GLP-1 (590)
Government (4420)
Healthcare (18852)
Infectious disease (2653)
Inflammatory bowel disease (107)
Interviews (329)
IPO (16442)
Job creations (3669)
Job search strategy (1503)
Layoffs (416)
Legal (7976)
Lung cancer (171)
Manufacturing (185)
Medical device (13262)
Medtech (13267)
Mergers & acquisitions (19425)
Metabolic disorders (408)
Neuroscience (1523)
NextGen Class of 2024 (6559)
Non-profit (4503)
Northern California (1487)
Obesity (236)
Opinion (186)
Patents (103)
People (57193)
Phase I (20079)
Phase II (28467)
Phase III (21235)
Pipeline (460)
Postmarket research (2597)
Preclinical (8553)
Radiopharmaceuticals (243)
Rare diseases (221)
Real estate (5948)
Regulatory (21744)
Research institute (2339)
Resumes & cover letters (361)
Southern California (1307)
Startups (3610)
United States (13578)
Vaccines (562)
Weight loss (172)
Date
Today (55)
Last 7 days (671)
Last 30 days (3719)
Last 365 days (35934)
2024 (32981)
2023 (40355)
2022 (51465)
2021 (55993)
2020 (54433)
2019 (46949)
2018 (35378)
2017 (32490)
2016 (31930)
2015 (37950)
2014 (31729)
2013 (26778)
2012 (29009)
2011 (29674)
2010 (27736)
Location
Africa (745)
Arizona (194)
Asia (37929)
Australia (6217)
California (3345)
Canada (1296)
China (256)
Colorado (150)
Connecticut (156)
Europe (81474)
Florida (462)
Georgia (117)
Illinois (345)
Indiana (196)
Kansas (96)
Maryland (576)
Massachusetts (2627)
Michigan (158)
Minnesota (273)
New Jersey (968)
New York (967)
North Carolina (721)
Northern California (1487)
Ohio (141)
Pennsylvania (848)
South America (1119)
Southern California (1307)
Texas (465)
Utah (91)
Washington State (362)
693,173 Results for "thermogenesis holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc. reported financial and operating results for the third quarter ended September 30, 2023, and provided a corporate business update.
November 13, 2023
·
8 min read
Biotech Bay
ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference
ThermoGenesis Holdings, Inc. today announced that Chris Xu , Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET.
September 6, 2023
·
1 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading.
November 8, 2023
·
3 min read
Business
ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, reported financial and operating results for the second quarter ended June 30, 2023, and provided a corporate business update.
August 10, 2023
·
8 min read
Business
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
ThermoGenesis Holdings, Inc. announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.
August 8, 2023
·
3 min read
Press Releases
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
·
23 min read
Press Releases
Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results
November 8, 2024
·
14 min read
Press Releases
ME Therapeutics Holdings Inc. Appoints Chief Business Officer
October 25, 2024
·
4 min read
Business
ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc. reported financial and operating results for the year ended December 31, 2022 and provided a corporate strategic update.
March 30, 2023
·
8 min read
Business
ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update
ThermoGenesis Holdings, Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, reported financial and operating results for the first quarter ended March 31, 2023 and provided a corporate strategic update.
May 15, 2023
·
8 min read
1 of 69,318
Next
